Klike la a si sa a se lage laprès ou!

Kounye a yo raple medikaman pou tansyon wo Losartan

Ekri pa editè

Mint Pharmaceuticals Inc. ap raple tout anpil tablèt losartan preskripsyon li yo, nan 50 mg ak 100 mg fòs, apre tès yo te jwenn yon enpurte azido (5-(4′-((5-(azidometil)-2-butil-4-chloro). -1H imidazol-1-yl)methyl)-[1,1′-biphenyl]-2-yl)-1H tetrazol) pi wo pase limit akseptab. Ekspozisyon alontèm nan enpurte a nan nivo ki pi wo a sa ki konsidere kòm san danje kapab potansyèlman ogmante risk kansè.

Ekri an lèt detache Zanmitay, PDF & Imèl

Tanpri gade konsèy konplè a pou plis enfòmasyon, tankou sa Kanadyen yo ta dwe fè ak travay Sante Kanada pou adrese pwoblèm enpurte azido yo jwenn nan sèten dwòg.

pwodwiKonpayiDINLòtEkspirasyon
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005006959avril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005006960avril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005006961avril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005006962avril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005006963avril 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005011154jen 2023
MINT-LOSARTAN/HCTZ 50/12.5 mg TABLETMint Pharmaceuticals Inc.023896572005011156jen 2023
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETMint Pharmaceuticals Inc.023896652005006807avril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETMint Pharmaceuticals Inc.023896652005006808avril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETMint Pharmaceuticals Inc.023896652005006809avril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLETMint Pharmaceuticals Inc.023896652005006810avril 2022
MINT-LOSARTAN/HCTZ 100/12.5 mg TABLET Mint Pharmaceuticals Inc.023896652105002149desanm 2022
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896731805012687Oktòb 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896731805012688Oktòb 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896731805012689Oktòb 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896731805012792Oktòb 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896731905001010desanm 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLET Mint Pharmaceuticals Inc.023896731905001011desanm 2021
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732005006947avril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732005006949avril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732005006950avril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732005006951avril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLET Mint Pharmaceuticals Inc.023896732005007297avril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732005007298avril 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732005013776Out 2023
MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETMint Pharmaceuticals Inc.023896732105002150desanm 2023
Ekri an lèt detache Zanmitay, PDF & Imèl

Sou otè a

editè

Editè an chèf se Linda Hohnholz.

Leave a Comment